VitalStone Financial LLC purchased a new position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,857 shares of the medical research company’s stock, valued at approximately $439,000. A number of other hedge […]
VitalStone Financial LLC purchased a new position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) during the fourth quarter, HoldingsChannel reports. The institutional investor purchased 1,857 shares of the medical research company’s stock, valued at approximately $439,000. Other hedge funds have also recently added to or reduced their stakes in the company. VisionPoint […]
Charles River Laboratories International (NYSE:CRL – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Saturday. A number of other equities analysts have also recently commented on CRL. Citigroup lifted their price objective on shares of Charles River Laboratories […]
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) shares dropped 4.1% on Thursday . The company traded as low as $220.44 and last traded at $223.00. Approximately 273,632 shares traded hands during trading, a decline of 50% from the average daily volume of 546,376 shares. The stock had previously closed at $232.56. Analysts […]
New York State Common Retirement Fund trimmed its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 131,078 shares of the medical research company’s stock after selling 5,565 […]